ABOUT US

The Founder

Muhammad Ateeque Dhedhi Bhyria

Founded in 1988 by Mr. Muhammad Ateeque Dhedhi Bhyria, a Filipino businessman, SAHAR INTERNATIONAL TRADING, INC. — Sahar Group Of Companies has rapidly evolved from a small family business distributing carpets and bed linens to one of the most eccentric and sought after healthcare products distributors nationwide.

SAHAR is a well-known importer and  distributor of an array of pharmaceuticals, biologics, medical devices, cosmetics, foods &  beverages, industrial oils and chemicals for various industries in the Philippines amongst  other goods and services. SAHAR is a thriving company operating in the Philippines in  various sectors for over 30 years and has multiple branches and sister companies around  the country as well as across the region, including Singapore.

SAHAR has over 350 pharmaceutical products in its portfolio and over 50 upcoming products are under registration. Specifically, SAHAR is prominent in its Vaccines & Dextrose Infusion endeavours.

SAHAR is an importer and distributor of quality medicines and healthcare products in the Philippines for over Twenty-five (25) years. SAHAR was the first to introduce the Atorvastatin (calcium tablet) product in the Philippine market after the innovator of this product. Adding to that, there are many more brands that SAHAR has established which in turn, have become the first choice by countless medical professionals.

 

Our CEO Mr. Adeel Dhedhi Bhyria

 Is a Singaporean businessman with interests in  Pharmaceuticals, Medical Devices, Biotechnology, Food Supplements, Cosmetics,  Petrochemicals and Information Technology. He is actively involved in international trade  and has consistently prospered year on year with valuable experience in every aspect of  the field.

He has been at the helm of his companies’ robust operations, leading the companies to exponential growth and expansion by introducing innovative and future ready products and services to their growing portfolio. These include new and upcoming ventures complementary to our existing line of businesses as well as entry in completely new sectors such as novel therapies, precision medicine, medical devices, biotechnology and chemicals.

Mr. Adeel posses excellent leadership qualities that allow him to get the most out of his  employees, to succeed as an organization. His leadership style is cherished and  exemplified by his colleagues. Being an eloquent person adds to his benefits as it allows  him to manage business related matters meaningfully. In his role, he oversees the  companies’ overall visions, strategies, and directions to build the companies into dynamic  world-class enterprises with professional and progressive corporate culture and  discipline. Fuelling his companies’ growth with a focused management and streamlined  operations driven by technology and data, they are always ready to move rapidly in  response to customers’ changing needs and demands.

Mr. Adeel is a dynamic business executive with leadership qualities and a rich skill set  who’s an active attendee at a myriad of exhibitions, seminars and workshops around the  world – which enhance his knowledge base and significantly enrich his skills. All this  simply adds more value to his vast experience. A believer in life-long learning and who is  very dedicated to learn new things to meet the needs of the industry, keeping his skills up  to date; he tries his best to benefit the country in many possible ways, and aims to  contribute to the economy at all times. 

 

Adeel Dhedhi Bhyria

Founder, CEO of Sahar  International Trading, Inc

Achievements

SAHAR is on the right track to commit to its clients and customers its genuine objective,  which is to overcome the monopolization on pharmaceutical products in the market to  eventually reduce the high prices of life-saving medicines in the market. The general  public will be the first recipients of its advocacy to introduce cheaper medicines in the  market. Adding to that, SAHAR also won major cases against world-class multination  pharmaceutical companies. 

 

Senate Of The Philippines – 15th Congress Meeting On QUALITY AFFORDABLE MEDICINE OVERSIGHT COMMITTEE

The QUALITY AFFORDABLE MEDICINE OVERSIGHT COMMITTEE (QAMOC) will be conducting  First Joint...

Molenzavir (Molnupiravir) an antiviral drug to treat COVID-19

Molenzavir (Molnupiravir) a groundbreaking new drug that has recently received emergency use...

Small pharmaceutical firms worried about the court’s ‘flip-flopping’

Small pharmaceutical firms are worried about the alleged new decision of a quasijudicial court...

Court favors the Cheaper Medicine act.

The decision of the court in the intrigue case filed against us is a good start for the...